Femara beats Tamoxifen for older breast cancer patients

(HealthScout) UPDATED 2009-08-24

A new study has found that letrozole (Femara) increases survival more than tamoxifen for postmenopausal women who have undergone surgery. In the study of 8,000 women with hormone receptor-positive breast cancer, researchers found that women who had five years of straight letrozole survived longer than women who took tamoxifen, or women who started with tamoxifen and moved on to letrozole. Read full story >

See all Breast Cancer News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyBreastCancerNetwork.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.

Sign in

MyBreastCancerNetwork.com

Femara beats Tamoxifen for older breast cancer patients

People who read this also read...

What the community is saying...

Making Sense of The New Mammography Recommendations

Angi